Share
Journal Information
Issue
Vol. 63. Issue 10.Pages 509-574 (December 2016)
Editorial
Endocrinology, diabetes and nutrition: The future is here
Dídac Mauricio, Ignacio Conget, Edelmiro Menéndez, Manuel Puig-Domingo
Endocrinol Nutr. 2016;63:509-10
Full text access
Original articles
Cardiovascular risk factors in scholars (RIVACANGAS)
Rocío Mera-Gallego, Patricia García-Rodríguez, Marta Fernández-Cordeiro, Ángeles Rodríguez-Reneda, Natalia Vérez-Cotelo, N. Floro Andrés-Rodríguez, J. Antonio Fornos-Pérez, Itxaso Rica-Echevarría
Endocrinol Nutr. 2016;63:511-8
Full text access
Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Irene Romera, Francisco Javier Ampudia-Blasco, Antonio Pérez, Bernat Ariño, Egon Pfarr, Sanja Giljanovic Kis, Ebrahim Naderali
Endocrinol Nutr. 2016;63:519-26
Full text access
Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Raúl Morano, Lucía Ruíz
Endocrinol Nutr. 2016;63:527-35
Full text access
Impact of diabetes education on type 1 diabetes mellitus control in children
Daniel E. Alonso Martín, M. Belén Roldán Martín, M. Ángeles Álvarez Gómez, Rosa Yelmo Valverde, María Martín-Frías, Milagros Alonso Blanco, Raquel Barrio Castellanos
Endocrinol Nutr. 2016;63:536-42
Full text access
Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
Roberto Nuño-Solinís, Edurne Alonso-Morán, Jose M. Arteagoitia Axpe, Patxi Ezkurra Loiola, Juan F. Orueta, Sonia Gaztambide
Endocrinol Nutr. 2016;63:543-50
Full text access
Review articles
Impact of obesity on bone metabolism
Juan J. López-Gómez, José L. Pérez Castrillón, Daniel A. de Luis Román
Endocrinol Nutr. 2016;63:551-9
Full text access
Gut microbiota and type 2 diabetes mellitus
Araceli Muñoz-Garach, Cristina Diaz-Perdigones, Francisco J. Tinahones
Endocrinol Nutr. 2016;63:560-8
Full text access
Scientific letters
Venlafaxine drug interaction in the diagnosis of pheochromocytoma
Ana Belén Mañas-Martínez, Alicia Aragoneses-Calvo, Ana Matei, Sylvie Ojeda-Rodríguez, Pilar García-Durruti
Endocrinol Nutr. 2016;63:569-70
Full text access
Bariatric surgery results in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion therapy
Jesus Moreno-Fernandez, Ana Chico
Endocrinol Nutr. 2016;63:571-2
Full text access
Letter to the editor
Statement on the current treatment of severe obesity in Spain
Felipe Casanueva, Felipe de la Cruz Vigo, Albert Goday, Juan Carlos Ruiz de Adana, Susana Monereo, Ramón Vilallonga, Purificación Martínez de Icaya, Raquel Sánchez-Santos, ... Ismael Díez del Val
Endocrinol Nutr. 2016;63:573-4
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History